The present invention relates generally to medical devices and more particularly to a device to disrupt a clot in a body vessel.
One medical condition that some patients suffer from his deep vein thrombosis (DVT). DVT most commonly affects the veins in the legs and can occur for a number of reasons. Typically, DVT occurs in patients with a reduced rate of blood flow or physiological conditions that make a patient's blood more susceptible to clotting. Although DVT can be uncomfortable and painful for patients due to swelling and decreased blood circulation in a patient's leg, DVT is particularly dangerous because it is possible for large blood clots to break loose from the blockage and flow through the venous system to the lungs. This can result in a pulmonary embolism, which can be fatal in certain cases.
Typically, DVT conditions can be identified early by observing the swelling and discomfort symptoms that often accompany DVT. Early conditions of DVT may be referred to as acute DVT, and in this stage, DVT is characterized by a buildup of clotted blood. In contrast, chronic DVT is characterized by the development of fibrous tissue that may become a more permanent blockage of the vein.
Commonly, DVT is treated with the use of thrombolytic drugs, such as tPA, which chemically dissolves clots. DVT has also been treated with intraluminal devices that rotate within the vessel to break up clots. Filters are also used downstream of a clotted region to catch any clots that break loose before the clots reach the lungs.
Although various methods currently exist for treating DVT, the inventor believes that an improved method and medical device would be desirable for treating DVT and possibly other conditions.
A magnetic wire and medical procedure are described for disrupting a clot in a body vessel. The wire has a magnet attached to a core. The magnet is disposed along a distal portion of the wire intended to be inserted into a patient's body vessel. The magnet is positioned adjacent a clot in the body vessel, and an exterior magnetic driver is positioned in proximity to the magnet. By alternating the magnetic field of the magnetic driver, the magnet and wire are moved laterally within the body vessel to disrupt the clot. The inventions herein may also include any other aspect described below in the written description, the claims, or in the attached drawings and any combinations thereof.
The invention may be more fully understood by reading the following description in conjunction with the drawings, in which:
Referring now to the figures, and particularly to
The wire 10a also includes a magnet 24a disposed along the distal portion 22 of the wire 10a. Various types of magnets 24 may be used with the wire 10, but in the embodiment of
Turning to
Turning to
Turning to
Once the magnet 24 is positioned adjacent the clot 32, a magnetic driver 46 is positioned outside the patient's body 48 in a location proximate to the magnet 24. A magnetic field 50 is then generated by the magnetic driver 46 so that the magnet 24 is attracted to and/or repelled from the magnetic driver 46. The magnetic field 50 may be alternated by repeatedly turning the field 50 on and off or by reversing the charge of the field 50. As a result, the magnet 24 and the portion of the wire 10 that the magnet 24 is connected to are repeatedly drawn toward the magnetic driver 46 and/or pushed away from the magnetic driver 46. This causes the wire 10 to repeatedly press laterally into the clot 32, which causes the clot 32 to break up. Preferably, the distal portion 22 of the core 12 that the magnet 24 is attached to as a smaller cross-sectional profile to make the distal portion 22 more flexible than the proximal portion 18 so that the magnet 24 readily moves laterally within the vessel 34 in response to the magnetic driver 46.
The broken up clots 52 may be dissolved using thrombolytic drugs, which may be injected through the annular space 54 between the wire 10 and the sheath 36. For example, the sheath 36 may be provided with a port 56 outside the patient's body 48 where the drugs may be injected into the sheath 36. A filter 58 may also be released in the vessel 34 at a location downstream from the magnet 24 and clot 32. Thus, when the clots 52 break loose, they are caught by the filter 58 before reaching vital organs. The clots 52 that are caught by the filter 58 may then be dissolved by thrombolytic drugs; may dissolve naturally due to the body's physiological processes; may be mechanically disrupted further by the filter 58; or may be removed from the body 48 by removing the filter 58. The broken clots 52 may also be collected by the sheath 36 by applying suction 60 to the annular space 54 between the sheath 36 and the wire 10. Negative pressure 60 may be applied by exerting suction 60 at the port 56 on the proximal end 62 of the sheath 36. Therefore, when positioning the sheath 36 in the vessel 34, it is desirable to locate the distal end 64 of the sheath 36 as close as possible to the clot 32 in order to exert suction pressure 60 onto the clot 32 and to release thrombolytic drugs directly at the clot 32.
After the magnetic driver 46 has been used to drive the wire 10 into the clot 32 to break up the clot 32, it may be desirable to rotate the magnetic driver 46 around the patient's body 48 and alternate the current again. This will cause the wire 10 to move laterally in the vessel 34 in a different plane from the first use of the magnetic driver 46. That is, because the wire 10 primarily moves along a plane toward and/or away from the magnetic driver 46, it may be useful to change the position of the magnetic driver 46 multiple times in order to drive the wire 10 along different lateral planes. For example, it may be desirable to rotate the magnetic driver 46 at least 60° from the first location to drive the wire 10 along a second plane. It may also be desirable to rotate the magnetic driver 46 about 90° from the first plane or other increments less than 60°. Alternatively, multiple magnetic drivers 46 may be used, either in separate steps or simultaneously.
One advantage of the wire 10 for use in disrupting clots 32 is the small profile of the wire 10 and the simplicity of the wire 10 itself. This may minimize trauma to the patient, and also, particularly to the valves 44 in a patient's vein 34. While the method does require an external magnetic driver 46 to force lateral movement of the wire 10 within the patient's vessel 34, the magnetic driver 46 may be a reusable piece of equipment in the physician's office. Thus, the single-use components are limited to the wire 10 and the sheath 36 and/or filter 58. In addition, physicians may find the procedure simpler and more desirable than other devices once physicians become comfortable with the use of an exterior magnetic driver 46 to move a wire 10 within a vessel 34 for the purpose of breaking up clots 32. While the wire 10 may be used in other medical procedures, it is believed that the wire 10 may be especially useful in treating deep vein thrombosis, and particularly, for treating acute clots 32 before a clot 32 has developed significant fibrous tissue or other hardened structures. Chronic clots and other obstructions may benefit less from the described method because such structures typically involve a more integrated and solid structure that is less amenable to being broken up by the lateral movement expected from the described method.
While preferred embodiments of the invention have been described, it should be understood that the invention is not so limited, and modifications may be made without departing from the invention. The scope of the invention is defined by the appended claims, and all devices that come within the meaning of the claims, either literally or by equivalence, are intended to be embraced therein. Furthermore, the advantages described above are not necessarily the only advantages of the invention, and it is not necessarily expected that all of the described advantages will be achieved with every embodiment of the invention.
This application claims priority to U.S. Provisional Application No. 61/591,658, filed Jan. 27, 2012, which is hereby incorporated by reference herein.
Number | Date | Country | |
---|---|---|---|
61591658 | Jan 2012 | US |